220 related articles for article (PubMed ID: 2411122)
1. Intravenous use of amrinone for the treatment of the failing heart.
Mancini D; LeJemtel T; Sonnenblick E
Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of intravenous amrinone in patients with congestive heart failure.
Goldstein RA
Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
Bottorff MB; Rutledge DR; Pieper JA
Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583
[TBL] [Abstract][Full Text] [Related]
4. Comparative vasoactive therapy for heart failure.
Benotti JR; McCue JE; Alpert JS
Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
[TBL] [Abstract][Full Text] [Related]
5. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
Robinson PJ; Lvoff R; Chong B; Barrett PA
Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of cardiac failure.
Weber KT; Janicki JS; Maskin CS
Am J Cardiol; 1985 Jul; 56(3):3B-7B. PubMed ID: 4025157
[TBL] [Abstract][Full Text] [Related]
8. Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction.
Taylor SH; Verma SP; Hussain M; Reynolds G; Jackson NC; Hafizullah M; Richmond A; Silke B
Am J Cardiol; 1985 Jul; 56(3):29B-32B. PubMed ID: 4025156
[TBL] [Abstract][Full Text] [Related]
9. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
[TBL] [Abstract][Full Text] [Related]
10. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
[TBL] [Abstract][Full Text] [Related]
11. Acute positive inotropic intervention: the phosphodiesterase inhibitors.
DiBianco R
Am Heart J; 1991 Jun; 121(6 Pt 1):1871-5. PubMed ID: 2035420
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with amrinone in patients with advanced congestive heart failure.
Kinney EL; Carlin B; Ballard JO; Burks JM; Hallahan WF; Zelis R
J Clin Pharmacol; 1982 Oct; 22(10):433-40. PubMed ID: 7174853
[TBL] [Abstract][Full Text] [Related]
13. [Effects of amrinone administered orally and by injection in heart failure].
Bounhoure JP; Massabuau P; Puel J; Miquel JP; Calazel J
Ann Med Interne (Paris); 1985; 136(3):251-5. PubMed ID: 3896092
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol.
Firth BG; Ratner AV; Grassman ED; Winniford MD; Nicod P; Hillis LD
Am J Cardiol; 1984 Dec; 54(10):1331-6. PubMed ID: 6507308
[TBL] [Abstract][Full Text] [Related]
15. Amrinone in the management of low cardiac output after open heart surgery.
Goenen M; Pedemonte O; Baele P; Col J
Am J Cardiol; 1985 Jul; 56(3):33B-38B. PubMed ID: 4025158
[TBL] [Abstract][Full Text] [Related]
16. Effects of amrinone on myocardial energetics in severe congestive heart failure.
Baim DS
Am J Cardiol; 1985 Jul; 56(3):16B-18B. PubMed ID: 3161318
[TBL] [Abstract][Full Text] [Related]
17. Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.
Wilmshurst PT; Thompson DS; Juul SM; Dittrich HC; Dawson JR; Walker JM; Jenkins BS; Coltart DJ; Webb-Peploe MM
Br Heart J; 1985 May; 53(5):493-506. PubMed ID: 3994862
[TBL] [Abstract][Full Text] [Related]
18. New positive inotropic drugs for the treatment of congestive heart failure.
Sonnenblick EH; Mancini DM; LeJemtel TH
Am J Cardiol; 1985 Jan; 55(2):41A-44A. PubMed ID: 2981465
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
[TBL] [Abstract][Full Text] [Related]
20. [Amrinone in acute and long-term therapy].
Klepzig M; Kleinhans E; Büll U; Strauer BE
Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
